By Giulia Petroni

Bayer AG said Tuesday that it appointed Christian Rommel as the new head of research and development at its pharmaceuticals division, effective from Feb. 1.

The German pharmaceutical and chemical conglomerate said Mr. Rommel will succeed Joerg Moeller, who decided to leave the company effective Dec. 31 to pursue other career opportunities.

Mr. Rommel will serve on the pharmaceuticals executive committee and report to Stefan Oelrich, the division's president and a member of the board of management.

Prior to joining Bayer, Mr. Rommel served as senior vice president and global head of oncology research and early development at Hoffmann-La Roche AG.

Write to Giulia Petroni at giulia.petroni@wsj.com

(END) Dow Jones Newswires

October 27, 2020 09:31 ET (13:31 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bayer Charts.
Bayer (TG:BAYN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bayer Charts.